Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
05:49am, Thursday, 16'th Jan 2025
It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much.
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
02:47pm, Tuesday, 14'th Jan 2025
On Sunday, Vertex Pharmaceuticals Incorporated VRTX announced multiple program updates, including:
NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
05:01pm, Sunday, 12'th Jan 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company's scheduled w
SHANGHAI & CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and
BOSTON & SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and
Vertex Recognized in Built In's Esteemed 2025 Best Places to Work Awards
10:00am, Thursday, 09'th Jan 2025
KING OF PRUSSIA, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, was recognized on Built In's 50
Here's Why You Should Add Vertex Stock to Your Portfolio Now
12:31pm, Tuesday, 07'th Jan 2025
VERX's strong portfolio, increasing customer base and product integrations make it a compelling investment option at present.
Vertex Grapples With Bearish Chart As Death Cross Emerges
12:23pm, Tuesday, 07'th Jan 2025
Vertex Pharmaceuticals Inc VRTX is grappling with bearish technical signals as its stock forms a dreaded Death Cross.
Best Momentum Stocks to Buy for January 7th
11:25am, Tuesday, 07'th Jan 2025
NN, VERX and AORT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 7, 2024.
New Strong Buy Stocks for January 7th
08:21am, Tuesday, 07'th Jan 2025
AORT, VERX, NN, IMCR and EVER have been added to the Zacks Rank #1 (Strong Buy) List on January 7, 2024.
NEW YORK, NY / ACCESSWIRE / January 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX)
Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested
09:02am, Tuesday, 31'st Dec 2024
Vertex Pharmaceuticals' suzetrigine showed lackluster Phase II results, but I still see potential in the non-addictive pain management market given the opioid crisis. Vertex's dominance in the cystic
S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points
08:00am, Saturday, 28'th Dec 2024
S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes to a close. The post S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy P
Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip
08:30am, Thursday, 26'th Dec 2024
Vertex Pharmaceuticals (VRTX 0.72%) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from a late-stage clinical trial. But far from being a reason to doubt
